J David Gladstone Institutes
- Assets
- $367.5m
- Revenue
- $143.0m
- Investments
- $90.1m
- Employees
- 579
- Location
- San Francisco, CA
- Founding
- 06/1973
- Data as of
- 12/2021
- EIN
- 23-7203666
Organization Overview
J David Gladstone Institutes is located in San Francisco, CA. The organization was established in 1973. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. As of 12/2023, J David Gladstone Institutes employed 579 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. J David Gladstone Institutes is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, J David Gladstone Institutes generated $143.0m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 11.5% each year . All expenses for the organization totaled $103.0m during the year ending 12/2021. While expenses have increased by 3.2% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TO DRIVE A NEW ERA OF DISCOVERY IN DISEASE ORIENTED SCIENCE AND TO MENTOR TOMORROW'S LEADERS IN AN INSPIRING AND DIVERSE ENVIRONMENT.
Describe the Organization's Program Activity:
THE INSTITUTE OF NEUROLOGICAL DISEASE MAINTAINS A STRONG FOCUS ON NEURODEGENERATIVE AND NEUROINFLAMMATORY DISEASES, INCLUDING ALZHEIMER'S DISEASE AND OTHER DEMENTIAS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS (ALS), AND MULTIPLE SCLEROSIS. THE INVESTIGATORS ARE SEARCHING FOR COMMON THREADS THAT WILL ALLOW THEM TO IDENTIFY THERAPEUTIC INTERVENTIONS THAT MIGHT BENEFIT MULTIPLE CONDITIONS. THEY ARE USING UNCONVENTIONAL APPROACHES TO IDENTIFY SUCH MULTI-FACETED SOLUTIONS, WHILE ALSO LEVERAGING CAPABILITIES IN REGENERATIVE AND PERSONALIZED MEDICINE.
THE GLADSTONE INSTITUTE OF DATA SCIENCE AND BIOTECHNOLOGY INVESTS IN TALENT TO CREATE NEW WAYS TO ANALYZE AND INTEGRATE DATASETS, INCLUDING MACHINE LEARNING APPROACHES THAT LEVERAGE THE RAPID ADVANCES IN ARTIFICIAL INTELLIGENCE. IT WILL BE THE HOME FOR DEVELOPMENT OF NEW TECHNOLOGIES THAT CAN ACCELERATE DISCOVERY IN ALL AREAS OF INVESTIGATION AT GLADSTONE. GLADSTONE - UCSF INSTITUTE OF GENOMIC IMMUNOLOGY BLENDS THE LATEST GENOMICS AND GENOME ENGINEERING TECHNOLOGIES WITH IMMUNOLOGY RESEARCH TO ENGINEER THE HUMAN IMMUNE SYSTEM FOR THERAPEUTIC BENEFIT.
THE INSTITUTE OF VIROLOGY HAS MADE SIGNIFICANT CONTRIBUTIONS TO FIGHT HIV/AIDS, SARS-COV-2, HEPATITIS C, ZIKA, AND CYTOMEGALOVIRUS INFECTIONS LEADING TO GLOBAL AND GROUNDBREAKING EFFORTS IN HIV PREVENTION AND CURE. ITS STATE OF THE ART BSL3 LABORATORIES HAVE ALLOWED GLADSTONE TO DO GROUNDBREAKING WORK IN UNDERSTANDING THE COVID-19 VIRUS AND OTHER VIRUS DRIVEN DISEASES. BY FOCUSING ON PREVENTION, DIAGNOSIS, AND THERAPEUTICS, THE INSTITUTE AIMS TO DEVELOP PROACTIVE STRATEGIES TO TACKLE CURRENT AND FUTURE PANDEMICS.
THE INSTITUTE OF CARDIOVASCULAR DISEASE LEVERAGES IMPORTANT GENETIC, DEVELOPMENTAL, CHEMICAL, BIOLOGICAL SYSTEMS, COMPUTATIONAL, AND ENGINEERING APPROACHES TO STUDY HEART DISEASE AND STEM CELL BIOLOGY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Nicholas J Simon Trustee | Trustee | 3 | $425,000 |
Andrew S Garb Trustee | Trustee | 3 | $425,000 |
William Price Trustee | Trustee | 3 | $425,000 |
Deepak Srivastava President | Officer | 40 | $1,027,331 |
Robert Obana COO | Officer | 40 | $597,259 |
Warner Greene Director | Officer | 40 | $522,014 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Schwegman Lundberg Woessner Legal Services | 12/30/22 | $728,186 |
Service By Medallion Custodial Services | 12/30/22 | $657,116 |
Dg Architects Inc Architectural Services | 12/30/22 | $251,473 |
Goodwin Procter Llp Legal Services | 12/30/22 | $146,259 |
Moss Adams Llp Accounting Services | 12/30/22 | $194,277 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Total Revenue from Contributions, Gifts, Grants & Similar | $70,616,690 |
| Investment income | $2,852,448 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $106,076 |
| Net Gain/Loss on Asset Sales | $3,560,030 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $143,049,979 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $6,644,310 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $35,576,413 |
| Pension plan accruals and contributions | $2,936,814 |
| Other employee benefits | $7,718,275 |
| Payroll taxes | $2,680,072 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $573,753 |
| Fees for services: Accounting | $222,580 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $411,200 |
| Fees for services: Other | $11,768,805 |
| Advertising and promotion | $0 |
| Office expenses | $9,819,175 |
| Information technology | $983,050 |
| Royalties | $30,000 |
| Occupancy | $5,455,429 |
| Travel | $235,148 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $6,958,160 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $6,501,017 |
| Insurance | $1,431,130 |
| All other expenses | $0 |
| Total functional expenses | $103,017,350 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $8,253,357 |
| Savings and temporary cash investments | $1,434,010 |
| Pledges and grants receivable | $52,867,768 |
| Accounts receivable, net | $5,124,046 |
| Loans from Officers, Directors, or Controlling Persons | $1,075,000 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $1,016,998 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $2,288,643 |
| Investments—publicly traded securities | $104,948,168 |
| Investments—other securities | $90,091,564 |
| Investments—program-related | $0 |
| Intangible assets | $4,985,842 |
| Other assets | $13,040,127 |
| Total assets | $367,466,101 |
| Accounts payable and accrued expenses | $5,483,351 |
| Grants payable | $0 |
| Deferred revenue | $10,824,120 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $159,025,000 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $16,008,312 |
| Total liabilities | $191,340,783 |
| Net assets without donor restrictions | $117,208,843 |
| Net assets with donor restrictions | $58,916,475 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Total liabilities and net assets/fund balances | $176,125,318 |